46.29
-1.17(-2.47%)
Currency In CNY
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
4619
First IPO Date
June 06, 2001
| Name | Title | Pay | Year Born |
| Ms. Lei Wang | Chairman of the Board | 0 | 1971 |
| Mr. Yu Zhang | Chief Manufacturing Officer | 0 | 1973 |
| Mr. Jian Ma | Chief Financial Officer | 0 | 1978 |
| Ms. Yan Jiao | Secretary to the Board of Directors | 0 | 1977 |
| Mr. Hong Zhou | Deputy GM, Chief Engineer & Executive Director | 0 | 1970 |
| Mr. Min Guo | Executive Director | 0 | 1971 |
| Mr. Mingjie Shang | Executive Director | 0 | 1969 |
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and healthcare products primarily in the People's Republic of China. It operates in Chinese Medicine and Western Medicine segments. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; wholesale and retail sale of medicines, biochemical pharmaceutical products, and daily use products; and operation of hospitals. In addition, it provides logistics, stocks, equipment installation, and medicine processing services; medicine inspection and testing services; and pharmaceutical consultancy services. The company sells its medicinal products under its own brand to the wholesalers; and purchases medicinal products under other brands from distributors and sells these to other wholesalers. The company was formerly known as Tianjin Zhong Xin Pharmaceutical Group Corporation Limited and changed its name to Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited in May 2022. Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited was incorporated in 1992 and is based in Tianjin, the People's Republic of China.